Cleveland Clinic
Specialty Services Symposium: Medical, Surgical and Quality
June 3, 2008 InterContinental Hotel & Bank of America Conference Center | Cleveland, Ohio

Sharing World-class Developments With You...

Cleveland Clinic puts patients first in everything we do.  Our institute model of care was designed so that the focus of care delivery is on patients and their diseases, regardless of the specialties involved.  Everything from the structure of our buildings, the design of our patient gowns and the training received by our caregivers puts patients in the middle to leverage all aspects of our clinical expertise and promote healing.

One of the most relevant examples of putting patients first comes from the exciting field of Genomic Medicine.  In Genomics, patients' specific genetic information is translated into improved diagnostic screening and clinical care.  Cleveland Clinic's Center for Personalized Genetic Healthcare is one of the nation's leading authorities in the field of Cancer Genetics.  Our Cancer Genetics Clinic is led by 1 of 4, formally trained Clinical Cancer Geneticists in the United States and supported by clinically trained genetics counselors.  Our ability to personalize medical management for patients empowers them to be more proactive about personal surveillance, make informed medical decisions, reduce possible health complications and improve overall health outcomes.  If you would like to learn more about Genomic Medicine at Cleveland Clinic, please visit http://my.clevelandclinic.org/genomics-genetics/genetic-genomic-medicine.aspx.

In this issue you will have the opportunity to learn more about some of the services provided by Taussig Cancer Institute, which is ranked #1 in Ohio and #9 in the USA in U.S.News & World Report.  The center sees more than 280,000 patients per year, with a carefully integrated clinical and translational research program.  Taussig Cancer Institute covers all malignancies, with a particular emphasis on genitourinary oncology, hematological malignancy, myelodysplastic syndrome, thoracic oncology, brain tumors, stem cell biology, new drug development and patient support services.

I hope you enjoy the Fall 2010 issue of Speaking of Specialty Services.
As always, we welcome your feedback.

Sincerely,
Michael McMillan
Executive Director,
Market and Network Services,
Cleveland Clinic





Return to Current Issue